- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BLU
Recent news which mentions BLU
From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
July 07, 2023
From Benzinga
GSK Stock: A Value Trap or a Hidden Gem?
April 27, 2023
From InvestorPlace
3 Biotechs That Might Get Bought Out in 2023
April 26, 2023
From Motley Fool
Was This Acquisition a Savvy Play by This Big Pharma Stock?
April 26, 2023
From Motley Fool
Why This Nasdaq Stock Caught Fire This Week
April 20, 2023
From Motley Fool
Why Shares of Bellus Health Skyrocketed This Week
April 20, 2023
From Motley Fool
From Benzinga
Dow Edges Higher; Goldman Sachs Posts Upbeat Earnings
April 18, 2023
From Benzinga
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 18, 2023
From Benzinga
From Benzinga
Why BELLUS Health Stock Is Rocketing Higher Today
April 18, 2023
From Motley Fool
From Benzinga
US Stocks Mixed; Housing Starts Edge Lower In March
April 18, 2023
From Benzinga
From Benzinga
Why Is Gamida Cell (GMDA) Stock Up 48% Today?
April 18, 2023
From InvestorPlace
Why Is ContraFect (CFRX) Stock Down 14% Today?
April 18, 2023
From InvestorPlace
Why Is VirnetX (VHC) Stock Down 63% Today?
April 18, 2023
From InvestorPlace
Bellus Health’s stock climbs on GSK deal, while Goldman Sachs is hurt by a revenue miss
April 18, 2023
From MarketWatch
Why Is Bellus Health (BLU) Stock Up 98% Today?
April 18, 2023
From InvestorPlace
Why Digital Brands Group Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket
April 18, 2023
From Benzinga
From InvestorPlace
From MarketWatch
BELLUS Health, Sunrun And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
April 18, 2023
From Benzinga
GSK To Strengthen Specialty Medicines and Respiratory Pipeline With $2B BELLUS Health Acquisition
April 18, 2023
From Benzinga
GSK to acquire U.S.-based BELLUS Health for $14.75 per share
April 18, 2023
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.